ARCA and Laboratory Corporation of America (NYSE: LH) have jointly developed the companion diagnostic for Gencaro. LabCorp provided the companion diagnostic test and testing services to support the GENETIC-AF Phase 2B clinical trial. LabCorp is the world’s leading healthcare diagnostics company. www.labcorp.com
ARCA’s founding scientists are affiliated with the University of Colorado, and important biotechnology that is under development by ARCA had its origins in University laboratories. ARCA is proud of its longstanding partnership and licensing agreement with the University.
ARCA biopharma is dedicated to establishing mutually beneficial long-term relationships with our partners to improve the health of cardiovascular patients around the world. Our partnering strategy for Gencaro is focused on development and commercialization collaborations in which we retain U.S. commercial and/or co-promotion rights. We are also actively seeking in-licensing opportunities involving clinical stage therapeutics addressing cardiovascular diseases.
Please contact: Chris Ozeroff at email@example.com for business development and partnering inquiries.